Endometriosis News and Research

Latest Endometriosis News and Research

The AFA and IntegraMed partner to provide innovative fertility education programs

The AFA and IntegraMed partner to provide innovative fertility education programs

StockPreacher.com releases investment report on Repros Therapeutics

StockPreacher.com releases investment report on Repros Therapeutics

Request for lift of full clinical hold on Proellex program

Request for lift of full clinical hold on Proellex program

Soligenix's revenues for 2009 increase by 22%

Soligenix's revenues for 2009 increase by 22%

Facts and treatment options for endometriosis

Facts and treatment options for endometriosis

Painful periods at early age doubles risk of endometriosis

Painful periods at early age doubles risk of endometriosis

Neurocrine Biosciences to sell common stock shares

Neurocrine Biosciences to sell common stock shares

Soligenix' LPM oral drug delivery technology receives Hong Kong patent

Soligenix' LPM oral drug delivery technology receives Hong Kong patent

Clinical research study conducted for patients with IC/PBS

Clinical research study conducted for patients with IC/PBS

Ipsen launches Decapeptyl LP 22.5 mg in France

Ipsen launches Decapeptyl LP 22.5 mg in France

Promising results from Soligenix' RiVax vaccine trials against ricin toxin

Promising results from Soligenix' RiVax vaccine trials against ricin toxin

Merck receives marketing authorization for ELONVA

Merck receives marketing authorization for ELONVA

Infertility can lead to isolation and impact on couple’s relationships

Infertility can lead to isolation and impact on couple’s relationships

Findings suggest abuse is a risk factor for chronic headache

Findings suggest abuse is a risk factor for chronic headache

Cryo-Cell International continues to expand R&D initiatives to accelerate therapeutic benefits of stem cells

Cryo-Cell International continues to expand R&D initiatives to accelerate therapeutic benefits of stem cells

Promising results from Soligenix' RiVax vaccine against ricin toxin

Promising results from Soligenix' RiVax vaccine against ricin toxin

Neurocrine to advance its NBI-98854 VMAT2 Inhibitor into a multiple repeated dose Phase 1 study

Neurocrine to advance its NBI-98854 VMAT2 Inhibitor into a multiple repeated dose Phase 1 study

Soligenix commences SGX201 Phase 1/2 clinical trial for acute radiation enteritis prevention

Soligenix commences SGX201 Phase 1/2 clinical trial for acute radiation enteritis prevention

Neurocrine Biosciences to sell 4,784,689 shares of common stock to Venrock affiliates

Neurocrine Biosciences to sell 4,784,689 shares of common stock to Venrock affiliates

Results from Tulip PETAL Study of elagolix announced by Neurocrine Biosciences

Results from Tulip PETAL Study of elagolix announced by Neurocrine Biosciences